(On the Site, Scroll down to Recommendations and Overview of Evidence sections for a shorter read.)

 

This is an old trick of governments… releasing important stuff to their foot-soldier minions in offices across the country, but not really wanting the general public to get involved with the discussion.

 

They issued new guidance today on something we should be getting front page headlines about, late on a Friday, so by Monday, it’s forgotten history.

 

 

I have a screen capture of their summary recommendations here so have at the details yourself, however the highlights for me are as follows:

 

1. They’ve removed “pregnant and lactating women” from their list of first people to get the needle, which I see as pretty darn good news!

 

2. There was such a dismal uptake of their fall mRNA needle program that they’re making another attempt to get that cohort in the Spring, by STRESSING that if you missed the Fall jab, you REALLY should get a needle in the spring![Leave me alone!! I made my choice!!]

 

3. They must be pretty worried about the shelf-life of the already purchased viles. I remember when they said it wasn’t safe to take a needle before at least 6 months, the interval between doses has suddenly dropped to 3 months!

 

4. Following up on that same shelf-life suspicion, they’re pushing the same product as last year, which is sure to be a dud come Spring. Why? Because it was designed for a variant that was around last Summer for their Fall, 2023 roll-out; but that is NOT the variant emerging now and spreading faster than any previous one.

 

There is zero data whatsoever on last year’s product on this Spring’s variant, so whether what they’re pushing for the Spring program will have any effectiveness at all, even for a very-short time is completely unknown.

 

I’ll not get into that new variant in this post, it’s late, but perhaps we’ll give people an update on it tomorrow.